In Silico Drug Prescription for Targeting Cancer Patient Heterogeneity and Prediction of Clinical Outcome

Cancers - Switzerland
doi 10.3390/cancers11091361
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

In-Silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-Omics Data

Scientific Reports
Multidisciplinary
2019English

PAMAM/5-fluorouracil Drug Conjugate for Targeting E6 and E7 Oncoproteins in Cervical Cancer: A Combined Experimental/in Silico Approach

RSC Advances
ChemistryChemical Engineering
2017English

In Silico Prescription of Anticancer Drugs to Cohorts of 28 Tumor Types Reveals Targeting Opportunities

Cancer Cell
Cancer ResearchOncologyCell Biology
2015English

Clonal Heterogeneity Influences Drug Responsiveness in Renal Cancer Assessed by Ex Vivo Drug Testing of Multiple Patient-Derived Cancer Cells

International Journal of Cancer
Cancer ResearchOncology
2018English

Apoptosis and Cancer Drug Targeting

Journal of Clinical Investigation
Medicine
1999English

In Silico Modeling of Immunotherapy and Stroma-Targeting Therapies in Human Colorectal Cancer

Cancer Research
Cancer ResearchOncology
2017English

Corrigendum: In Silico Prediction of Chemical Toxicity for Drug Design Using Machine Learning Methods and Structural Alerts

Frontiers in Chemistry
Chemistry
2018English

Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome

Clinical Cancer Research
Cancer ResearchOncology
2014English

Predictive Markers in Cancer Patient Diagnosis, Classification and Prediction of Therapy Outcome Using Leukaemia as a Model

EPMA Journal
BiochemistryHealth PolicyDrug Discovery
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy